Book the Most Important Interventional Cardiology Meetings in 2018

March 10-12 | ACC 2018 – American College of Cardiology 

The first major annual meeting is the American College of Cardiology (ACC), to be held in Orlando on March 10 thru 12, in Orlando (Florida).

Date: March 10, 11, 12.

Venue: Orange County Convention Center.

City: Orlando, Florida, US.

More information 

 

May 22-25 | EuroPCR 2018

The global leading course in interventional cardiology will make the headlines next May, when the new edition of this renowned event takes place at Palais des Congrès (Paris).

Date: May 22-25, 2018

Venue: Palais des Congrès,

City: Paris, France.

More information 

 

August 25-29 | ESC Congress 2018

This event, which last year gathered over 30,000 healthcare professionals from 150 different countries, will be back in August to keep adding value to our specialty, with prestigious international guests, invaluable must-see scientific sessions and ample industry participation.  

 

Date: August Saturday 25 – Wednesday 29, 2018 (5 days),

City: Munich, Germany.

More information  

 

September 21-25 | TCT 2018

Once more, the Cardiovascular Research Foundation (CRF) prepares for the new edition of the Transcatheter Cardiovascular Therapeutics (TCT), one of the favorite meetings in the field of interventional cardiology. The event will be held in the city of San Diego (CA), USA, from September 21 thru 25, 2018.

Date: September 21 thru 25, 2018

Venue: San Diego Convention Center 

City: San Diego, CA, US.

More information 

 

November 10-14 | AHA 2018 Scientific Sessions

2018 scientific sessions will close the year with important scientific advances, new technology, and new studies in the field. The meeting will take place in Chicago, Illinois, US, from November 10 thru 14, 2018. The venue will be the Chicago Convention Center.

Date: November 10-14, 2018

Venue: Chicago Convention Center.

City: Chicago, Illinois, US.

More information 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SOLACI Wishes You Happy Holidays

From the heart, Happy Holidays! The Latin American Society of Interventional Cardiology wishes all its members and the medical community across the continent a very Merry Christmas...

Condolences on the passing of Cristiam Arancibia

The Latin American Society of Interventional Cardiology deeply mourns the passing of Lic. Cristiam Arancibia, first Director of the Chapter of Technicians and Nurses,...

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

Moderate to severe mitral valve regurgitation (MR) continues is still a high prevalence condition with bad prognosis, particularly among the elderly with left ventricular...

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Despite steady progress in secondary prevention and medical treatment optimization (OMT), acute coronary syndrome (ACS) remains one of the leading causes of cardiovascular morbimortality....

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Balloon post-dilation (BPD) during transcatheter aortic valve replacement (TAVR) allows for the optimization of prosthesis expansion and the reduction of residual paravalvular aortic regurgitation....